$KRON
Kronos Bio, Inc.

2022 Q4 Form 10-Q Financial Statement

#000174183022000035 Filed on November 08, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $11.28M $10.90M $9.752M
YoY Change -8.68% 11.79% 78.94%
% of Gross Profit
Research & Development $22.40M $23.40M $24.69M
YoY Change -55.25% -5.2% 47.35%
% of Gross Profit
Depreciation & Amortization $574.0K $600.0K $500.0K
YoY Change 5.13% 20.0% 150.0%
% of Gross Profit
Operating Expenses $33.68M $33.54M $33.67M
YoY Change -46.03% -0.4% 61.82%
Operating Profit -$33.54M -$33.67M
YoY Change -0.4% 61.82%
Interest Expense $1.900M $1.282M $0.00
YoY Change 2538.89% -100.0%
% of Operating Profit
Other Income/Expense, Net $1.282M $70.00K
YoY Change 1731.43% -100.37%
Pretax Income -$31.78M -$32.26M -$33.60M
YoY Change -49.01% -4.01% -15.38%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$31.78M -$32.26M -$33.60M
YoY Change -49.01% -4.01% -15.39%
Net Earnings / Revenue
Basic Earnings Per Share -$0.57 -$0.61
Diluted Earnings Per Share -$0.56 -$0.57 -$611.2K
COMMON SHARES
Basic Shares Outstanding 56.90M shares 56.77M shares 56.25M shares
Diluted Shares Outstanding 56.32M shares 54.98M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $238.2M $258.3M $398.4M
YoY Change -29.84% -35.17% 88.54%
Cash & Equivalents $75.97M $67.48M $217.0M
Short-Term Investments $162.2M $190.8M $181.4M
Other Short-Term Assets $5.534M $5.768M $3.397M
YoY Change -23.45% 69.8% 142.64%
Inventory
Prepaid Expenses
Receivables $572.0K $607.0K $1.048M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $244.3M $264.6M $402.8M
YoY Change -29.71% -34.31% 89.22%
LONG-TERM ASSETS
Property, Plant & Equipment $12.99M $38.81M $42.56M
YoY Change -68.92% -8.81% 7.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $9.762M $12.09M $0.00
YoY Change -100.0%
Other Assets $1.167M $112.0K $112.0K
YoY Change 941.96% 0.0% -96.51%
Total Long-Term Assets $50.65M $53.04M $44.70M
YoY Change 15.31% 18.65% -9.99%
TOTAL ASSETS
Total Short-Term Assets $244.3M $264.6M $402.8M
Total Long-Term Assets $50.65M $53.04M $44.70M
Total Assets $294.9M $317.7M $447.5M
YoY Change -24.66% -29.02% 70.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.047M $1.462M $3.940M
YoY Change 405.71% -62.89% -11.32%
Accrued Expenses $12.96M $14.99M $7.350M
YoY Change 43.03% 104.0% 312.92%
Deferred Revenue $0.00
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $21.49M $20.11M $14.77M
YoY Change 57.68% 36.08% -91.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $209.0K $350.0K $1.406M
YoY Change -81.0% -75.11% -50.51%
Total Long-Term Liabilities $209.0K $350.0K $1.406M
YoY Change -81.0% -75.11% -50.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $21.49M $20.11M $14.77M
Total Long-Term Liabilities $209.0K $350.0K $1.406M
Total Liabilities $50.44M $49.98M $48.51M
YoY Change 8.75% 3.04% -77.54%
SHAREHOLDERS EQUITY
Retained Earnings -$396.2M -$364.4M -$200.7M
YoY Change 50.66% 81.61% 154.8%
Common Stock $57.00K $56.00K $55.00K
YoY Change 1.79% 1.82% 816.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $244.5M $267.7M $399.0M
YoY Change
Total Liabilities & Shareholders Equity $294.9M $317.7M $447.5M
YoY Change -24.66% -29.02% 70.45%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$31.78M -$32.26M -$33.60M
YoY Change -49.01% -4.01% -15.39%
Depreciation, Depletion And Amortization $574.0K $600.0K $500.0K
YoY Change 5.13% 20.0% 150.0%
Cash From Operating Activities -$22.53M -$22.39M -$20.14M
YoY Change -61.51% 11.19% 95.91%
INVESTING ACTIVITIES
Capital Expenditures $52.00K -$73.00K -$926.0K
YoY Change -110.88% -92.12% -77.79%
Acquisitions
YoY Change
Other Investing Activities $31.79M $3.180M $51.02M
YoY Change -18.96% -93.77% -407.16%
Cash From Investing Activities $31.74M $3.107M $50.09M
YoY Change -18.1% -93.8% -341.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -716.0K 628.0K 1.381M
YoY Change -168.19% -54.53% -99.07%
NET CHANGE
Cash From Operating Activities -22.53M -22.39M -20.14M
Cash From Investing Activities 31.74M 3.107M 50.09M
Cash From Financing Activities -716.0K 628.0K 1.381M
Net Change In Cash 8.492M -18.66M 31.34M
YoY Change -145.36% -159.55% -73.5%
FREE CASH FLOW
Cash From Operating Activities -$22.53M -$22.39M -$20.14M
Capital Expenditures $52.00K -$73.00K -$926.0K
Free Cash Flow -$22.58M -$22.32M -$19.21M
YoY Change -61.1% 16.17% 214.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001741830
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39592
dei Entity Registrant Name
EntityRegistrantName
Kronos Bio, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-1895605
dei Entity Address Address Line1
EntityAddressAddressLine1
1300 So. El Camino Real
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 400
dei Entity Address City Or Town
EntityAddressCityOrTown
San Mateo
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94402
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
781-5200
dei Security12b Title
Security12bTitle
Common stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
KRON
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
56898374 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67481000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
198270000 usd
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
190774000 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
141239000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6375000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8045000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
264630000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
347554000 usd
CY2022Q3 us-gaap Long Term Investments
LongTermInvestments
12086000 usd
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
0 usd
CY2022Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
13538000 usd
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
14880000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
25276000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
26904000 usd
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2026000 usd
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2026000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
112000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
112000 usd
CY2022Q3 us-gaap Assets
Assets
317668000 usd
CY2021Q4 us-gaap Assets
Assets
391476000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1462000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
998000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14994000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9063000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2239000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2109000 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1410000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1456000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
20105000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13626000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29526000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
31653000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
350000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1100000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
49981000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
46379000 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56439628 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56439628 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55703327 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55703327 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
56000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
56000 usd
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
633087000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
608064000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-364406000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-262984000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1050000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-39000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
267687000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
345097000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
317668000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
391476000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23403000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24688000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
70547000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
62084000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10135000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8985000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32886000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26908000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
33538000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
33673000 usd
us-gaap Operating Expenses
OperatingExpenses
103433000 usd
us-gaap Operating Expenses
OperatingExpenses
88992000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-33538000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-33673000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-103433000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-88992000 usd
CY2022Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
1282000 usd
CY2021Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
70000 usd
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
2011000 usd
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
248000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1282000 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
70000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2011000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
248000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-32256000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-33603000 usd
us-gaap Net Income Loss
NetIncomeLoss
-101422000 usd
us-gaap Net Income Loss
NetIncomeLoss
-88744000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-389000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1011000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
26000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32645000 usd
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-33602000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-102433000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-88718000 usd
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.81
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.81
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.63
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56318571 shares
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-491000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56318571 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54977085 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54977085 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56093091 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56093091 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54549747 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54549747 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
345097000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
529000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7788000 usd
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-131000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-36263000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
317020000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
375000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8207000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
35000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-32903000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
292243000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
628000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7461000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-389000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-32256000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
267687000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
465519000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
590000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5238000 usd
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-26086000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
445257000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
627000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6432000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
817000 usd
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
29000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-29055000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
424107000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1381000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7137000 usd
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-33603000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
399023000 usd
us-gaap Net Income Loss
NetIncomeLoss
-101422000 usd
us-gaap Net Income Loss
NetIncomeLoss
-88744000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1692000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1431000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-185000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-3175000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-856000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-211000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
23456000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
18807000 usd
kron Lease Expense Noncash
LeaseExpenseNoncash
1628000 usd
kron Lease Expense Noncash
LeaseExpenseNoncash
1487000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1433000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2843000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
0 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-54000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
409000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-650000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6161000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3288000 usd
kron Increase Decrease In Right Of Use Operating Assets And Liabilities Net
IncreaseDecreaseInRightOfUseOperatingAssetsAndLiabilitiesNet
1997000 usd
kron Increase Decrease In Right Of Use Operating Assets And Liabilities Net
IncreaseDecreaseInRightOfUseOperatingAssetsAndLiabilitiesNet
-399000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-799000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-1703000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-68398000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1567000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-59402000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
525000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3782000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
307181000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
163615000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
243248000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
175340000 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
500000 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
17032000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-63958000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
24975000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
5000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1532000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2598000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
35000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
817000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3410000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-130789000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-31017000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
200296000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
250036000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69507000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
219019000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
51000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
408000 usd
kron Right Of Use Asset Increase Decrease Due To Modification
RightOfUseAssetIncreaseDecreaseDueToModification
0 usd
kron Right Of Use Asset Increase Decrease Due To Modification
RightOfUseAssetIncreaseDecreaseDueToModification
-1741000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3764000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67481000 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
216993000 usd
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2026000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2026000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69507000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
219019000 usd
us-gaap Net Income Loss
NetIncomeLoss
-364400000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions reflected in these condensed financial statements include, but are not limited to, the accrual of research and development expenses, the fair value of investments, income tax uncertainties, the valuation of equity instruments and the incremental borrowing rate for determining the operating lease assets and liabilities. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Actual results could differ from the Company’s estimates.</span></div>
CY2022Q3 kron Cash And Cash Equivalent And Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss Current
CashAndCashEquivalentAndDebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent
258667000 usd
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1050000 usd
CY2022Q3 kron Cash And Cash Equivalent And Debt Securities Available For Sale Excluding Accrued Interest Current
CashAndCashEquivalentAndDebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
257617000 usd
CY2021Q4 kron Cash And Cash Equivalent And Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss Current
CashAndCashEquivalentAndDebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent
331976000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
41000 usd
CY2021Q4 kron Cash And Cash Equivalent And Debt Securities Available For Sale Excluding Accrued Interest Current
CashAndCashEquivalentAndDebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
331937000 usd
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
54757000 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
190698000 usd
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
190774000 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
141239000 usd
CY2022Q3 us-gaap Long Term Investments
LongTermInvestments
12086000 usd
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
0 usd
CY2022Q3 us-gaap Investments And Cash
InvestmentsAndCash
257617000 usd
CY2021Q4 us-gaap Investments And Cash
InvestmentsAndCash
331937000 usd
CY2022Q3 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
245531000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
143014000 usd
CY2022Q3 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
12086000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
0 usd
CY2022Q3 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
0 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
188923000 usd
CY2022Q3 us-gaap Investments And Cash
InvestmentsAndCash
257617000 usd
CY2021Q4 us-gaap Investments And Cash
InvestmentsAndCash
331937000 usd
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 usd
CY2021 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 usd
CY2022Q3 kron Debt Securities Available For Sale Accrued Interest
DebtSecuritiesAvailableForSaleAccruedInterest
607000 usd
CY2021Q4 kron Debt Securities Available For Sale Accrued Interest
DebtSecuritiesAvailableForSaleAccruedInterest
816000 usd
CY2022Q3 kron Prepaid Equipment Service Contracts
PrepaidEquipmentServiceContracts
321000 usd
CY2021Q4 kron Prepaid Equipment Service Contracts
PrepaidEquipmentServiceContracts
360000 usd
CY2022Q3 kron Prepaid External Research And Development And Outside Services
PrepaidExternalResearchAndDevelopmentAndOutsideServices
4144000 usd
CY2021Q4 kron Prepaid External Research And Development And Outside Services
PrepaidExternalResearchAndDevelopmentAndOutsideServices
3074000 usd
CY2022Q3 kron Prepaid Software
PrepaidSoftware
717000 usd
CY2021Q4 kron Prepaid Software
PrepaidSoftware
624000 usd
CY2022Q3 us-gaap Prepaid Insurance
PrepaidInsurance
129000 usd
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
2644000 usd
CY2022Q3 us-gaap Prepaid Rent
PrepaidRent
457000 usd
CY2021Q4 us-gaap Prepaid Rent
PrepaidRent
527000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6375000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8045000 usd
CY2022Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
18489000 usd
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
18139000 usd
CY2022Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
4951000 usd
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
3259000 usd
CY2022Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
13538000 usd
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
14880000 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
600000 usd
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
500000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1700000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1400000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3195000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4570000 usd
CY2022Q3 kron Accrued External Research And Development Current
AccruedExternalResearchAndDevelopmentCurrent
10923000 usd
CY2021Q4 kron Accrued External Research And Development Current
AccruedExternalResearchAndDevelopmentCurrent
2655000 usd
CY2022Q3 kron Accrued Outside Services Current
AccruedOutsideServicesCurrent
839000 usd
CY2021Q4 kron Accrued Outside Services Current
AccruedOutsideServicesCurrent
1598000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
37000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
240000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14994000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9063000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
957876 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
17.76
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
591463 shares
CY2022Q3 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
1056000 usd
CY2021Q4 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
1364000 usd
CY2022Q3 kron Espp Withholdings Liability Current
ESPPWithholdingsLiabilityCurrent
354000 usd
CY2021Q4 kron Espp Withholdings Liability Current
ESPPWithholdingsLiabilityCurrent
92000 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1410000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1456000 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6590400 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.33
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2708563 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.51
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.58
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7749624 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.07
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y2M26D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1372000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.52
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
40400000 usd
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
49900000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7461000 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7137000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23456000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18807000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-32256000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-33603000 usd
us-gaap Net Income Loss
NetIncomeLoss
-101422000 usd
us-gaap Net Income Loss
NetIncomeLoss
-88744000 usd
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56318571 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56318571 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54977085 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54977085 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56093091 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56093091 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54549747 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54549747 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.81
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.81
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.63
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10914210 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7889688 shares
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
25276000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
26904000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2239000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2109000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29526000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
31653000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
31765000 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
33762000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1278000 usd
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1023000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
3833000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
3787000 usd
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1900000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
4200000 usd
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1000000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
3300000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
812000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5581000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5749000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5921000 usd
CY2022Q3 kron Lessee Operating Lease Liability To Be Paid Year Four And Thereafter
LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter
26711000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
44774000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
13009000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
31765000 usd

Files In Submission

Name View Source Status
0001741830-22-000035-index-headers.html Edgar Link pending
0001741830-22-000035-index.html Edgar Link pending
0001741830-22-000035.txt Edgar Link pending
0001741830-22-000035-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kron-20220930.htm Edgar Link pending
kron-20220930.xsd Edgar Link pending
kron-20220930_g1.jpg Edgar Link pending
kronq3fy2022ex311.htm Edgar Link pending
kronq3fy2022ex312.htm Edgar Link pending
kronq3fy2022ex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
kron-20220930_def.xml Edgar Link unprocessable
kron-20220930_pre.xml Edgar Link unprocessable
kron-20220930_lab.xml Edgar Link unprocessable
kron-20220930_htm.xml Edgar Link completed
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
kron-20220930_cal.xml Edgar Link unprocessable